RU95101019A - Method of preparing tumor necrosis factor, tumor necrosis factor, dna, cell, composition - Google Patents

Method of preparing tumor necrosis factor, tumor necrosis factor, dna, cell, composition

Info

Publication number
RU95101019A
RU95101019A RU95101019/14A RU95101019A RU95101019A RU 95101019 A RU95101019 A RU 95101019A RU 95101019/14 A RU95101019/14 A RU 95101019/14A RU 95101019 A RU95101019 A RU 95101019A RU 95101019 A RU95101019 A RU 95101019A
Authority
RU
Russia
Prior art keywords
necrosis factor
tumor necrosis
dna
preparing
cell
Prior art date
Application number
RU95101019/14A
Other languages
Russian (ru)
Inventor
Бхасан Аггарвал Бхарат
In]
Ваннорман Геддель Давид
Ни Ли Санг
Us]
Эван Недвин Гленн
Original Assignee
Генентек
Генентек, Инк.
Инк. (US)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Генентек, Генентек, Инк., Инк. (US) filed Critical Генентек
Publication of RU95101019A publication Critical patent/RU95101019A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

FIELD: molecular biology, medicine. SUBSTANCE: invention presents recombinant tumor necrosis factor, method of its preparing and therapeutic compositions involving the indicated tumor necrosis factor, the corresponding encoding DNA-sequences and host cells used for tumor necrosis factor DNA expression. EFFECT: improved method of preparing.

Claims (1)

Представлены рекомбинантный фактор некроза опухоли и способ его получения. Изобретение также относится к терапевтическим композициям, включающим указанный фактор некроза (опухоли, кодирующим ДНК-последовательностям и хозяйским клеткам, используемым д я экспрессии ДНК фактора некроза опухоли.Presents a recombinant tumor necrosis factor and method for its preparation. The invention also relates to therapeutic compositions comprising said necrosis factor (tumors, coding for DNA sequences and host cells used to express tumor necrosis factor DNA.
RU95101019/14A 1984-07-05 1995-01-17 Method of preparing tumor necrosis factor, tumor necrosis factor, dna, cell, composition RU95101019A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US62805984A 1984-07-05 1984-07-05
US06/628060 1984-07-05
US06/627959 1984-07-05
US06/628059 1984-07-05
US06/677257 1984-12-03
US06/677454 1984-12-03
US06/677156 1984-12-03

Publications (1)

Publication Number Publication Date
RU95101019A true RU95101019A (en) 1996-12-27

Family

ID=24517272

Family Applications (2)

Application Number Title Priority Date Filing Date
SU3955012 RU2076151C1 (en) 1984-07-05 1985-07-04 Method of preparing the tumor necrosis factor, human tumor necrosis factor
RU95101019/14A RU95101019A (en) 1984-07-05 1995-01-17 Method of preparing tumor necrosis factor, tumor necrosis factor, dna, cell, composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SU3955012 RU2076151C1 (en) 1984-07-05 1985-07-04 Method of preparing the tumor necrosis factor, human tumor necrosis factor

Country Status (2)

Country Link
RU (2) RU2076151C1 (en)
ZA (1) ZA855059B (en)

Also Published As

Publication number Publication date
ZA855059B (en) 1987-03-25
RU2076151C1 (en) 1997-03-27

Similar Documents

Publication Publication Date Title
MY101852A (en) Tumor necrosis factor, methods for its preparation, containing it, dna encoding it and assay method using such dna.
HUT38125A (en) Process for preparing lymphokines /cytotoxic factors/ and pharmaceutical compositions containing such active substance
RU94046367A (en) Dna, host cell, method of protein preparing, protein, pharmaceutical preparation, antibody, use of antibody
RU95108217A (en) Defective recombinant adenovirus, cell strain, pharmaceutical composition
MY101887A (en) A novel human physiologically active polypeptide.
ATE380866T1 (en) TNF RECEPTOR-ASSOCIATED FACTOR MODULATORS, THEIR PREPARATION AND USES
HUP9903921A2 (en) A tumor necrosis factor related ligand
IT1298487B1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING PENTRAXIN LONG PTX3 FOR THE THERAPY OF INFECTIOUS, INFLAMMATORY OR CANCER TYPE DISEASES,
EP0232523A3 (en) Dna sequences which encode for proteins with the biological activity of husi-type i inhibitors, their production by gene technology and drugs containing these proteins
DE3583634D1 (en) GENE TECHNOLOGICAL METHOD FOR PRODUCING HUMAN INTERLEUKIN-2 AND MEANS FOR CARRYING OUT THIS METHOD.
FI902569A0 (en) PRODUCERING AV TILL GONORRE ANSLUTANDE PI-PROTEINER OCH VACCIN.
ATE90354T1 (en) POLYDEOXYRIBONUCLEOTIDES, PHARMACEUTICAL COMPOSITIONS, USE AND PRODUCTION OF POLYDEOXYRIBONUCLEOTIDES.
RU95101019A (en) Method of preparing tumor necrosis factor, tumor necrosis factor, dna, cell, composition
ATE233321T1 (en) IMPROVEMENTS IN THE PRODUCTION OF PROTEINS IN HOST CELLS
WO1992019281A3 (en) New conjugates, consisting of a glycoprotein and a nucleic acid-binding substance
ATE87977T1 (en) PREPARATION OF HUMAN SOMATOMEDINS C.
ES8802250A1 (en) A method for obtaining DNA which codes for mutant tumour necrosis factor